Big Data and Cognitive Computing Events Announce Your Event Here

20–21 September 2018 16th Annual Pharmaceutical IT Congress

London, UK

The 16th Annual Pharmaceutical IT Congress is part of PharmaTec Event Series that features 3 outstanding programmes: our long-running Pharma IT Congress and fast-emerging Artificial Intelligence in Drug Development and Digital Health & Digital Technologies Congresses.

This event will host over 300 attendees who will be representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

There will be over 27 presentations and case studies focusing on the key developments in Big Data, R&D informatics, translational informatics, NGS informatics and Bioinformatics, and real-world evidence and real-world data.

Our world-renowned experts will be presenting across 3 interactive streams, including;

  • Big Data Led Strategies & Innovation
  • R&D Informatics, Translational Informatics, NGS Informatics and Bioinformatics
  • Management of Real-World Evidence and Real-World Data

This event will once again be co-located with the 2nd Annual Artificial Intelligence in Drug Development Congress. This year the congress will also be co-located with the highly anticipated inaugural Digital Health & Digital Technologies Congress.

Free Pre-Congress Live Webinar

Federated & Harmonised Real-World Research in the EU 2020+: A Convergence of Intent, Collaboration & Technology
Nigel Hughes, Scientific Director, National Heart, Lung, and Blood and Shanrong Zhao, Director Computational Biology and Bioinformatics, Pfizer 

Register here >>

For further information, prices & discounts please contact a.saez@oxfordglobal.co.uk or click here: https://bit.ly/2nLs4cc   

Alternatively visit our website

https://bit.ly/2BIikcm

20–21 September 2018 Digital Health & Digital Technologies Congress

London, UK

The Digital Health & Digital Technologies Congress is part of PharmaTec Event Series that features 3 outstanding programmes: our long-running Pharma IT Congress and fast-emerging Artificial Intelligence in Drug Development and Digital Health & Digital Technologies Congresses.

This event will host over 300 attendees who will be representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

There will be over 18 presentations and case studies focusing on the key developments in digital health and digital therapeutics looking at critical areas such as digital health regulations, patient engagement, wearable technologies, digital therapeutic technologies and optimising real-time technology in clinical trials.

Our world-renowned experts will be presenting across 2 interactive streams, including;

  • Digital Health Strategies
  • Designing and Developing Digital Therapeutics

The inaugural Digital Health & Digital Technologies Congress will be co-located with both the 16th Annual Pharmaceutical IT Congress and 2nd Annual Artificial Intelligence in Drug Development Congress.

 

Free Pre-Congress Live Webinar

Software and Prescription Medical Treatments
David Benshoof Klein, Co-Founder & CEO, Click Therapeutics, Inc. 

Register here >>

 For further information, prices & discounts please contact a.saez@oxfordglobal.co.uk or click here: https://bit.ly/2E9DeOX  

Alternatively visit our website

https://bit.ly/2sjf3fR

20–21 September 2018 2nd Annual Artificial Intelligence in Drug Development Congress

London, UK

The 2nd Annual Artificial Intelligence in Drug Development Congress is part of PharmaTec Event Series that features 3 outstanding programmes: our long-running Pharma IT Congress and fast-emerging Artificial Intelligence in Drug Development and Digital Health & Digital Technologies Congresses.

This event will host over 300 attendees who will be representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

There will be over 30 presentations and case studies focussed on the innovative application of artificial intelligence in drug discovery and cheminformatics, alongside machine learning in clinical trials and big data.

Our world-renowned experts will be presenting across 3 interactive streams, including;

  • AI in Drug Discovery and Discovery Chemistry
  • Machine Learning and Personalising Patient Treatments
  • AI in Big Data and Clinical Research Development

This event will once again be co-located with the 16th Annual Pharmaceutical IT Congress. This year the congress will also be co-located with the highly anticipated inaugural Digital Health & Digital Technologies Congress.

Free Pre-Congress Live Webinars

 

Artificial Intelligence in Drug Development: The Opportunity
Slava Akmaev, Chief Analytics Officer, BERG Health 

Register here >>

 AI-Driven Pre-Clinical Drug Design, Discovery and Development
George Okafo, Senior Director Insilico Drug Discovery Unit, GlaxoSmithKline 

Register here >>

 For further information, prices & discounts please contact a.saez@oxfordglobal.co.uk or click here: https://bit.ly/2Bf0OeS   

Alternatively visit our websi

https://bit.ly/2EozKvC

21–23 November 2018 Artificial Intelligence International Conference – A2IC 2018

Pompeu Fabra University – Balmes bulding, Carrer de Balmes 132, Barcelona, Spain

The A2IC conference aims to establish an international forum of reference for the latest advances in the field of Artificial Intelligence (AI). This first edition aims at joining both academy an industry by covering not only basic and applied research, but also philosophical and ethical issues regarding the future of humanity in an AI world.

http://premc.org/conferences/a2ic-artificial-intelligence/

26–28 November 2018 Kaleidoscope 2018: Machine learning for a 5G future

Santa Fe, Argentina

Kaleidoscope 2018: Machine learning for a 5G future is the tenth in a series of peer-reviewed academic conferences organized by ITU to bring together a wide range of views from universities, industry and research institutions. The aim of the Kaleidoscope conferences is to identify emerging developments in information and communication technologies (ICTs) and, in particular, areas in need of international standards to aid the healthy development of the Information Society.
Machine learning shows promise to assist smarter use of network-generated data, enabling ICT network operators and service providers to adapt to changes in traffic patterns, security risks and user behaviour. This will also affect ITU standardization work in fields such as coding algorithms; data collection, storage and management; and network management and orchestration.
Kaleidoscope 2018 calls for original scientific papers addressing advances in research on machine learning and artificial intelligence techniques for future communication networks, covering all aspects of network design, management, implementation and optimization. This year's conference will assist ITU standardization experts in capitalizing on machine learning in their preparations for the 5G era and beyond. Authors of outstanding papers will be invited to contribute to the work of ITU-T Focus Group on Machine Learning for Future Networks including 5G.
For additional information on Kaleidoscope 2018, please refer to the website.

https://www.itu.int/en/ITU-T/academia/kaleidoscope/2018/Pages/default.aspx

30 November–1 December 2017 Global Pharma R&D Informatics Congress

Lisbon, Portugal

Increasing amounts of data is constantly being generated form a wide number of sources. This creates a great opportunity to extract new insights into how diseases work and how drugs can be developed to provide more targeted and effective treatments, but only if pharma and biotech companies can structure, integrate, and analyse this data to derive useful knowledge from it.

The industry therefore needs to develop new methods and utilise new technologies to get the best out of the information available as well as integrate their internal systems so that all teams get the information they need in a way they can understand in order to accelerate the drug development pipeline.

This conference is the perfect opportunity to learn about these developments and network with experts working in all areas of pharmaceutical R&D IT and discovery informatics.

http://www.global-engage.com/event/global-pharma/

17–20 April 2018 3rd edition of Globe-IoT 2018: Towards Global Interoperability among IoT Systems jointly held with The International Conference on Cloud Engineering (IC2E) 2018 and the ACM/IEEE Internet of Things Design and Implementation (IoTDI) Conference 2018

Orlando, Florida, USA

While still in its infancy, the IoT domain already lists a number of solutions implemented, ranging from devices to platforms. However, the heterogeneity at all levels of those solution is preventing different solutions to interoperate effectively, despite a large number of efforts in the development of a unique reference standard for IoT systems technology. The situation is likely to worsen in the near future, as lack of interoperability causes major technological and business-oriented issues such as impossibility to plug non-interoperable IoT devices into heterogeneous IoT platforms, impossibility to develop IoT applications exploiting multiple platforms in homogeneous and/or cross domains, slowness of IoT technology introduction at large-scale, discouragement in adopting IoT technology, increase of costs, scarce reusability of technical solutions, security and privacy problems, user dissatisfaction.

This Workshop aims at investigating such lack of interoperability in the IoT realm by welcoming paper submissions providing innovative research as well as technical contributions on providing solutions to interoperability, integration, and interconnection of heterogeneous IoT systems, at any specific level (device, networking, middleware, application services, data and semantics) and at global platform level.

Topics of interest include, but are not limited to:

  • Interoperable and open IoT architectures
  • Service Virtualization in the IoT
  • Integration methods for heterogeneous IoT platforms
  • Interconnection of heterogeneous IoT devices
  • Enabling communication technologies (5G, SDN, Fog computing) for IoT interoperability
  • Software engineering for IoT systems development
  • Interoperable wearable devices and body area networks
  • Interoperable and open Big Data models for IoT
  • Matching non-interoperable IoT ontologies and semantics
  • Security, privacy and trust in IoT systems integration/interconnection
  • Standard interoperability mechanisms for the IoT
  • Interoperability use cases in IoT application domains (m-Health, transportation and logistics, smart factory, smart grid, smart home and buildings, smart cities, etc)

http://plasma.dimes.unical.it/events/Globe-IoT2018/

27–28 September 2017 15th Annual Pharmaceutical IT Congress

London, UK

Oxford Global Conferences are proud to present the 15th Annual Pharmaceutical IT Congress co-located with our Artificial Intelligence in Drug Development Congress, taking place on the 27-28 September 2017 in London.

200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

40 presentations and case studies focusing on the key developments in in Big Data and analytics, lab informatics, collaboration, digital health, wearable technologies, blockchain technology, lab automation and challenges in data privacy.

Including 4 interactive streams:

  • Getting the most out of big data in R&D IT
  • Translational Science and Medicine
  • Data Management, Real-World Evidence & Real-World Data
  • IT Solutions

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our Artificial Intelligence in Drug Development Congress.

Free Pre-Congress Webinars

Workflow Management in Analytical R&D Labs
Hosted by Jan Hauβ, Merck KGaA.

Click here to register today, for free.

Pre-Competitive Collaborations: Realising Benefits and Overcoming Challenges
Hosted by Christopher Hart, AstraZeneca and Nigel Hughes, Janssen Research and Development.

Click here to register today, for free.

http://bit.ly/1CZv606

27–28 September 2017 Artificial Intelligence in Drug Development Congress

London, UK

Oxford Global Conferences are proud to present the Artificial Intelligence in Drug Development Congress co-located with our 15th Annual Pharmaceutical IT Congress, taking place on the 27-28 September 2017 in London.

Over 250 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug development and clinical research, alongside novel diagnostic tools using artificial intelligence.

Including 3 Interactive Streams:

  • Artificial Intelligence (AI) in Drug Discovery and Development
  • Artificial Intelligence (AI) in Big Data and Clinical Research Development
  • Diagnostics and Medical Imaging in Healthcare

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 15th Annual Pharmaceutical IT Congress .

Free Pre-Congress Webinars

Artificial Intelligence in Drug Development
Hosted by Rafael Depetris, Principal Scientist I, Kadmon Corporation

Click here to register today, for free.

Artificial Intelligence and Big Data Management
Hosted by Ed Addison, CEO, Cloud Pharmaceuticals

Click here to register today, for free.

http://bit.ly/2loppVW

Back to Top